company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,,2010-06-30,2010-08-09 17:17:09+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,75668846.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,,2010-06-30,2010-08-09 17:17:09+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,301657.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,,2010-06-30,2010-08-09 17:17:09+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,140769863.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,,2010-06-30,2010-08-09 17:17:09+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,17925573.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,,2010-06-30,2010-08-09 17:17:09+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,20014655.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,,2010-06-30,2010-08-09 17:17:09+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5524663.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,,2010-06-30,2010-08-09 17:17:09+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,3574901.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,,2010-06-30,2010-08-09 17:17:09+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,263780158.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,,2010-06-30,2010-08-09 17:17:09+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,2787706.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,,2010-06-30,2010-08-09 17:17:09+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,22657254.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,,2010-06-30,2010-08-09 17:17:09+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,6762444.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,,2010-06-30,2010-08-09 17:17:09+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,29419698.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,,2010-06-30,2010-08-09 17:17:09+00:00,,totalassets,Total Assets,=,debit,usd,295987562.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,,2010-06-30,2010-08-09 17:17:09+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,7695799.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,,2010-06-30,2010-08-09 17:17:09+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,7124717.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,,2010-06-30,2010-08-09 17:17:09+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,17351673.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,,2010-06-30,2010-08-09 17:17:09+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,38594477.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,,2010-06-30,2010-08-09 17:17:09+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,70766666.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,,2010-06-30,2010-08-09 17:17:09+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,11061021.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,,2010-06-30,2010-08-09 17:17:09+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,91142856.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,,2010-06-30,2010-08-09 17:17:09+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,318500.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,,2010-06-30,2010-08-09 17:17:09+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,102522377.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,,2010-06-30,2010-08-09 17:17:09+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,173289043.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,,2010-06-30,2010-08-09 17:17:09+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,578883546.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,,2010-06-30,2010-08-09 17:17:09+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-456194336.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,,2010-06-30,2010-08-09 17:17:09+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,9309.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,,2010-06-30,2010-08-09 17:17:09+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,122698519.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,,2010-06-30,2010-08-09 17:17:09+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,122698519.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,,2010-06-30,2010-08-09 17:17:09+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,122698519.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q2,,2010-06-30,2010-08-09 17:17:09+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,295987562.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,,2010-09-30,2010-11-09 16:32:09+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,82404827.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,,2010-09-30,2010-11-09 16:32:09+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,301848.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,,2010-09-30,2010-11-09 16:32:09+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,163412360.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,,2010-09-30,2010-11-09 16:32:09+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,18228831.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,,2010-09-30,2010-11-09 16:32:09+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,26181863.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,,2010-09-30,2010-11-09 16:32:09+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5722357.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,,2010-09-30,2010-11-09 16:32:09+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,3260669.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,,2010-09-30,2010-11-09 16:32:09+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,299512755.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,,2010-09-30,2010-11-09 16:32:09+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3320957.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,,2010-09-30,2010-11-09 16:32:09+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,22013430.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,,2010-09-30,2010-11-09 16:32:09+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,6574046.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,,2010-09-30,2010-11-09 16:32:09+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,28587476.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,,2010-09-30,2010-11-09 16:32:09+00:00,,totalassets,Total Assets,=,debit,usd,331421188.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,,2010-09-30,2010-11-09 16:32:09+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,7525462.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,,2010-09-30,2010-11-09 16:32:09+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,17363236.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,,2010-09-30,2010-11-09 16:32:09+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,25803985.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,,2010-09-30,2010-11-09 16:32:09+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,38755613.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,,2010-09-30,2010-11-09 16:32:09+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,89448296.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,,2010-09-30,2010-11-09 16:32:09+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,10506761.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,,2010-09-30,2010-11-09 16:32:09+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,88785714.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,,2010-09-30,2010-11-09 16:32:09+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,318500.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,,2010-09-30,2010-11-09 16:32:09+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,99610975.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,,2010-09-30,2010-11-09 16:32:09+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,189059271.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,,2010-09-30,2010-11-09 16:32:09+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,586096924.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,,2010-09-30,2010-11-09 16:32:09+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-443757145.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,,2010-09-30,2010-11-09 16:32:09+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,22138.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,,2010-09-30,2010-11-09 16:32:09+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,142361917.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,,2010-09-30,2010-11-09 16:32:09+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,142361917.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,,2010-09-30,2010-11-09 16:32:09+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,142361917.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2010.0,Q3,,2010-09-30,2010-11-09 16:32:09+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,331421188.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,,2011-03-31,2011-05-09 07:29:47+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,78457000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,,2011-03-31,2011-05-09 07:29:47+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,302000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,,2011-03-31,2011-05-09 07:29:47+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,146890000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,,2011-03-31,2011-05-09 07:29:47+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,23795000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,,2011-03-31,2011-05-09 07:29:47+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,44795000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,,2011-03-31,2011-05-09 07:29:47+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,7098000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,,2011-03-31,2011-05-09 07:29:47+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,4343000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,,2011-03-31,2011-05-09 07:29:47+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,305680000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,,2011-03-31,2011-05-09 07:29:47+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3594000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,,2011-03-31,2011-05-09 07:29:47+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,20707000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,,2011-03-31,2011-05-09 07:29:47+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,6226000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,,2011-03-31,2011-05-09 07:29:47+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,26933000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,,2011-03-31,2011-05-09 07:29:47+00:00,,totalassets,Total Assets,=,debit,usd,336207000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,,2011-03-31,2011-05-09 07:29:47+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,3123000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,,2011-03-31,2011-05-09 07:29:47+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,19184000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,,2011-03-31,2011-05-09 07:29:47+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,25774000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,,2011-03-31,2011-05-09 07:29:47+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,39993000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,,2011-03-31,2011-05-09 07:29:47+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,88074000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,,2011-03-31,2011-05-09 07:29:47+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,8419000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,,2011-03-31,2011-05-09 07:29:47+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,84535000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,,2011-03-31,2011-05-09 07:29:47+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,391000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,,2011-03-31,2011-05-09 07:29:47+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,93345000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,,2011-03-31,2011-05-09 07:29:47+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,181419000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,,2011-03-31,2011-05-09 07:29:47+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,595835000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,,2011-03-31,2011-05-09 07:29:47+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-440758000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,,2011-03-31,2011-05-09 07:29:47+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-329000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,,2011-03-31,2011-05-09 07:29:47+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,40000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,,2011-03-31,2011-05-09 07:29:47+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,154788000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,,2011-03-31,2011-05-09 07:29:47+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,154788000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,,2011-03-31,2011-05-09 07:29:47+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,154788000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q1,,2011-03-31,2011-05-09 07:29:47+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,336207000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,,2011-06-30,2011-08-08 17:12:20+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,48635000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,,2011-06-30,2011-08-08 17:12:20+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,302000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,,2011-06-30,2011-08-08 17:12:20+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,179565000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,,2011-06-30,2011-08-08 17:12:20+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,23416000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,,2011-06-30,2011-08-08 17:12:20+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,42145000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,,2011-06-30,2011-08-08 17:12:20+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,7457000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,,2011-06-30,2011-08-08 17:12:20+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,4333000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,,2011-06-30,2011-08-08 17:12:20+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,305853000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,,2011-06-30,2011-08-08 17:12:20+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3543000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,,2011-06-30,2011-08-08 17:12:20+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,20502000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,,2011-06-30,2011-08-08 17:12:20+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,6197000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,,2011-06-30,2011-08-08 17:12:20+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,26699000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,,2011-06-30,2011-08-08 17:12:20+00:00,,totalassets,Total Assets,=,debit,usd,336095000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,,2011-06-30,2011-08-08 17:12:20+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,2941000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,,2011-06-30,2011-08-08 17:12:20+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,16706000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,,2011-06-30,2011-08-08 17:12:20+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,24998000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,,2011-06-30,2011-08-08 17:12:20+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,37931000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,,2011-06-30,2011-08-08 17:12:20+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,82576000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,,2011-06-30,2011-08-08 17:12:20+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,8122000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,,2011-06-30,2011-08-08 17:12:20+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,82271000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,,2011-06-30,2011-08-08 17:12:20+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,374000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,,2011-06-30,2011-08-08 17:12:20+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,90767000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,,2011-06-30,2011-08-08 17:12:20+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,173343000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,,2011-06-30,2011-08-08 17:12:20+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,604012000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,,2011-06-30,2011-08-08 17:12:20+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-441043000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,,2011-06-30,2011-08-08 17:12:20+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,329000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,,2011-06-30,2011-08-08 17:12:20+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,112000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,,2011-06-30,2011-08-08 17:12:20+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,163410000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,,2011-06-30,2011-08-08 17:12:20+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,162752000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,,2011-06-30,2011-08-08 17:12:20+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,162752000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q2,,2011-06-30,2011-08-08 17:12:20+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,336095000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,,2011-09-30,2011-11-07 17:18:05+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,44385000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,,2011-09-30,2011-11-07 17:18:05+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,303000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,,2011-09-30,2011-11-07 17:18:05+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,224428000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,,2011-09-30,2011-11-07 17:18:05+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,20608000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,,2011-09-30,2011-11-07 17:18:05+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,29769000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,,2011-09-30,2011-11-07 17:18:05+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,7099000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,,2011-09-30,2011-11-07 17:18:05+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,7781000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,,2011-09-30,2011-11-07 17:18:05+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,334373000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,,2011-09-30,2011-11-07 17:18:05+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3595000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,,2011-09-30,2011-11-07 17:18:05+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,7053000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,,2011-09-30,2011-11-07 17:18:05+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,6077000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,,2011-09-30,2011-11-07 17:18:05+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,13130000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,,2011-09-30,2011-11-07 17:18:05+00:00,,totalassets,Total Assets,=,debit,usd,351098000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,,2011-09-30,2011-11-07 17:18:05+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,2879000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,,2011-09-30,2011-11-07 17:18:05+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,13943000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,,2011-09-30,2011-11-07 17:18:05+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,19239000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,,2011-09-30,2011-11-07 17:18:05+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,38376000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,,2011-09-30,2011-11-07 17:18:05+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,0.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,,2011-09-30,2011-11-07 17:18:05+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,74437000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,,2011-09-30,2011-11-07 17:18:05+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,7801000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,,2011-09-30,2011-11-07 17:18:05+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,80007000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,,2011-09-30,2011-11-07 17:18:05+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1937000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,,2011-09-30,2011-11-07 17:18:05+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,89745000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,,2011-09-30,2011-11-07 17:18:05+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,164182000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,,2011-09-30,2011-11-07 17:18:05+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,609351000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,,2011-09-30,2011-11-07 17:18:05+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-422175000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,,2011-09-30,2011-11-07 17:18:05+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,329000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,,2011-09-30,2011-11-07 17:18:05+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,69000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,,2011-09-30,2011-11-07 17:18:05+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,187574000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,,2011-09-30,2011-11-07 17:18:05+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,186916000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,,2011-09-30,2011-11-07 17:18:05+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,186916000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2011.0,Q3,,2011-09-30,2011-11-07 17:18:05+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,351098000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,,2012-03-31,2012-05-09 15:39:34+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,55300000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,,2012-03-31,2012-05-09 15:39:34+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,303000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,,2012-03-31,2012-05-09 15:39:34+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,222945000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,,2012-03-31,2012-05-09 15:39:34+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,21526000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,,2012-03-31,2012-05-09 15:39:34+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,28659000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,,2012-03-31,2012-05-09 15:39:34+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,8201000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,,2012-03-31,2012-05-09 15:39:34+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,10780000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,,2012-03-31,2012-05-09 15:39:34+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,347714000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,,2012-03-31,2012-05-09 15:39:34+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,6521000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,,2012-03-31,2012-05-09 15:39:34+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,17046000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,,2012-03-31,2012-05-09 15:39:34+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,8950000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,,2012-03-31,2012-05-09 15:39:34+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,5821000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,,2012-03-31,2012-05-09 15:39:34+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,31817000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,,2012-03-31,2012-05-09 15:39:34+00:00,,totalassets,Total Assets,=,debit,usd,386052000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,,2012-03-31,2012-05-09 15:39:34+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,2348000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,,2012-03-31,2012-05-09 15:39:34+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,20010000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,,2012-03-31,2012-05-09 15:39:34+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,20487000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,,2012-03-31,2012-05-09 15:39:34+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,39212000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,,2012-03-31,2012-05-09 15:39:34+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,0.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,,2012-03-31,2012-05-09 15:39:34+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,82057000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,,2012-03-31,2012-05-09 15:39:34+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,6034000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,,2012-03-31,2012-05-09 15:39:34+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,75478000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,,2012-03-31,2012-05-09 15:39:34+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,3389000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,,2012-03-31,2012-05-09 15:39:34+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,84901000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,,2012-03-31,2012-05-09 15:39:34+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,166958000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,,2012-03-31,2012-05-09 15:39:34+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,621092000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,,2012-03-31,2012-05-09 15:39:34+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-401635000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,,2012-03-31,2012-05-09 15:39:34+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,329000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,,2012-03-31,2012-05-09 15:39:34+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-34000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,,2012-03-31,2012-05-09 15:39:34+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,219752000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,,2012-03-31,2012-05-09 15:39:34+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,219094000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,,2012-03-31,2012-05-09 15:39:34+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,219094000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q1,,2012-03-31,2012-05-09 15:39:34+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,386052000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,,2012-06-30,2012-08-08 17:12:45+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,64717000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,,2012-06-30,2012-08-08 17:12:45+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,303000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,,2012-06-30,2012-08-08 17:12:45+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,191133000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,,2012-06-30,2012-08-08 17:12:45+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,23607000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,,2012-06-30,2012-08-08 17:12:45+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,29413000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,,2012-06-30,2012-08-08 17:12:45+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,8655000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,,2012-06-30,2012-08-08 17:12:45+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,9409000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,,2012-06-30,2012-08-08 17:12:45+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,327237000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,,2012-06-30,2012-08-08 17:12:45+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,14290000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,,2012-06-30,2012-08-08 17:12:45+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,47118000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,,2012-06-30,2012-08-08 17:12:45+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,8755000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,,2012-06-30,2012-08-08 17:12:45+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,5653000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,,2012-06-30,2012-08-08 17:12:45+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,61526000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,,2012-06-30,2012-08-08 17:12:45+00:00,,totalassets,Total Assets,=,debit,usd,403053000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,,2012-06-30,2012-08-08 17:12:45+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,2459000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,,2012-06-30,2012-08-08 17:12:45+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,19721000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,,2012-06-30,2012-08-08 17:12:45+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,28205000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,,2012-06-30,2012-08-08 17:12:45+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,38048000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,,2012-06-30,2012-08-08 17:12:45+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,0.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,,2012-06-30,2012-08-08 17:12:45+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,88433000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,,2012-06-30,2012-08-08 17:12:45+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,5702000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,,2012-06-30,2012-08-08 17:12:45+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,73214000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,,2012-06-30,2012-08-08 17:12:45+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,6054000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,,2012-06-30,2012-08-08 17:12:45+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,84970000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,,2012-06-30,2012-08-08 17:12:45+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,173403000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,,2012-06-30,2012-08-08 17:12:45+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,627108000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,,2012-06-30,2012-08-08 17:12:45+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-397090000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,,2012-06-30,2012-08-08 17:12:45+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,329000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,,2012-06-30,2012-08-08 17:12:45+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-39000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,,2012-06-30,2012-08-08 17:12:45+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,230308000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,,2012-06-30,2012-08-08 17:12:45+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,229650000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,,2012-06-30,2012-08-08 17:12:45+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,229650000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q2,,2012-06-30,2012-08-08 17:12:45+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,403053000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,,2012-09-30,2012-11-08 16:55:45+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,40026000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,,2012-09-30,2012-11-08 16:55:45+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,469000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,,2012-09-30,2012-11-08 16:55:45+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,192204000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,,2012-09-30,2012-11-08 16:55:45+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,23227000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,,2012-09-30,2012-11-08 16:55:45+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,19240000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,,2012-09-30,2012-11-08 16:55:45+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,8180000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,,2012-09-30,2012-11-08 16:55:45+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,9483000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,,2012-09-30,2012-11-08 16:55:45+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,292829000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,,2012-09-30,2012-11-08 16:55:45+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,16437000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,,2012-09-30,2012-11-08 16:55:45+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,86434000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,,2012-09-30,2012-11-08 16:55:45+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,9279000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,,2012-09-30,2012-11-08 16:55:45+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,5474000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,,2012-09-30,2012-11-08 16:55:45+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,101187000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,,2012-09-30,2012-11-08 16:55:45+00:00,,totalassets,Total Assets,=,debit,usd,410453000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,,2012-09-30,2012-11-08 16:55:45+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,2479000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,,2012-09-30,2012-11-08 16:55:45+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,18460000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,,2012-09-30,2012-11-08 16:55:45+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,23243000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,,2012-09-30,2012-11-08 16:55:45+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,37857000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,,2012-09-30,2012-11-08 16:55:45+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,0.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,,2012-09-30,2012-11-08 16:55:45+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,82039000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,,2012-09-30,2012-11-08 16:55:45+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,5452000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,,2012-09-30,2012-11-08 16:55:45+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,70949000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,,2012-09-30,2012-11-08 16:55:45+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,6546000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,,2012-09-30,2012-11-08 16:55:45+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,82947000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,,2012-09-30,2012-11-08 16:55:45+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,164986000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,,2012-09-30,2012-11-08 16:55:45+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,633223000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,,2012-09-30,2012-11-08 16:55:45+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-387496000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,,2012-09-30,2012-11-08 16:55:45+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,329000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,,2012-09-30,2012-11-08 16:55:45+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,69000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,,2012-09-30,2012-11-08 16:55:45+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,246125000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,,2012-09-30,2012-11-08 16:55:45+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,245467000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,,2012-09-30,2012-11-08 16:55:45+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,245467000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2012.0,Q3,,2012-09-30,2012-11-08 16:55:45+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,410453000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,,2013-03-31,2013-05-10 11:03:17+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,34687000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,,2013-03-31,2013-05-10 11:03:17+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,34000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,,2013-03-31,2013-05-10 11:03:17+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,248659000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,,2013-03-31,2013-05-10 11:03:17+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,23288000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,,2013-03-31,2013-05-10 11:03:17+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,28586000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,,2013-03-31,2013-05-10 11:03:17+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,7606000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,,2013-03-31,2013-05-10 11:03:17+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,36955000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,,2013-03-31,2013-05-10 11:03:17+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,11060000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,,2013-03-31,2013-05-10 11:03:17+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,390875000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,,2013-03-31,2013-05-10 11:03:17+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,16936000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,,2013-03-31,2013-05-10 11:03:17+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,41559000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,,2013-03-31,2013-05-10 11:03:17+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,9446000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,,2013-03-31,2013-05-10 11:03:17+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,101545000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,,2013-03-31,2013-05-10 11:03:17+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,5062000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,,2013-03-31,2013-05-10 11:03:17+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,157612000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,,2013-03-31,2013-05-10 11:03:17+00:00,,totalassets,Total Assets,=,debit,usd,565423000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,,2013-03-31,2013-05-10 11:03:17+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,2324000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,,2013-03-31,2013-05-10 11:03:17+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,24077000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,,2013-03-31,2013-05-10 11:03:17+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,31786000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,,2013-03-31,2013-05-10 11:03:17+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,38677000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,,2013-03-31,2013-05-10 11:03:17+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,0.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,,2013-03-31,2013-05-10 11:03:17+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,96864000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,,2013-03-31,2013-05-10 11:03:17+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,4024000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,,2013-03-31,2013-05-10 11:03:17+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,66421000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,,2013-03-31,2013-05-10 11:03:17+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,6475000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,,2013-03-31,2013-05-10 11:03:17+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,76920000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,,2013-03-31,2013-05-10 11:03:17+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,173784000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,,2013-03-31,2013-05-10 11:03:17+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,647547000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,,2013-03-31,2013-05-10 11:03:17+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-255662000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,,2013-03-31,2013-05-10 11:03:17+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,329000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,,2013-03-31,2013-05-10 11:03:17+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,83000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,,2013-03-31,2013-05-10 11:03:17+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,392297000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,,2013-03-31,2013-05-10 11:03:17+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,391639000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,,2013-03-31,2013-05-10 11:03:17+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,391639000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q1,,2013-03-31,2013-05-10 11:03:17+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,565423000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,,2013-06-30,2013-08-08 17:11:41+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,42702000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,,2013-06-30,2013-08-08 17:11:41+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,41000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,,2013-06-30,2013-08-08 17:11:41+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,260627000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,,2013-06-30,2013-08-08 17:11:41+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,27055000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,,2013-06-30,2013-08-08 17:11:41+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,31690000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,,2013-06-30,2013-08-08 17:11:41+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,7096000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,,2013-06-30,2013-08-08 17:11:41+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,32935000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,,2013-06-30,2013-08-08 17:11:41+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,10759000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,,2013-06-30,2013-08-08 17:11:41+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,412905000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,,2013-06-30,2013-08-08 17:11:41+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,17740000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,,2013-06-30,2013-08-08 17:11:41+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,29050000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,,2013-06-30,2013-08-08 17:11:41+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,9875000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,,2013-06-30,2013-08-08 17:11:41+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,101453000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,,2013-06-30,2013-08-08 17:11:41+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,4883000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,,2013-06-30,2013-08-08 17:11:41+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,145261000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,,2013-06-30,2013-08-08 17:11:41+00:00,,totalassets,Total Assets,=,debit,usd,575906000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,,2013-06-30,2013-08-08 17:11:41+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,2318000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,,2013-06-30,2013-08-08 17:11:41+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,21189000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,,2013-06-30,2013-08-08 17:11:41+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,34211000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,,2013-06-30,2013-08-08 17:11:41+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,39142000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,,2013-06-30,2013-08-08 17:11:41+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,0.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,,2013-06-30,2013-08-08 17:11:41+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,96860000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,,2013-06-30,2013-08-08 17:11:41+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,3918000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,,2013-06-30,2013-08-08 17:11:41+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,64156000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,,2013-06-30,2013-08-08 17:11:41+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,6174000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,,2013-06-30,2013-08-08 17:11:41+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,74248000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,,2013-06-30,2013-08-08 17:11:41+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,171108000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,,2013-06-30,2013-08-08 17:11:41+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,656824000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,,2013-06-30,2013-08-08 17:11:41+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-251751000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,,2013-06-30,2013-08-08 17:11:41+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,329000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,,2013-06-30,2013-08-08 17:11:41+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,54000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,,2013-06-30,2013-08-08 17:11:41+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,405456000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,,2013-06-30,2013-08-08 17:11:41+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,404798000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,,2013-06-30,2013-08-08 17:11:41+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,404798000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q2,,2013-06-30,2013-08-08 17:11:41+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,575906000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,,2013-09-30,2013-11-07 17:23:11+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,46266000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,,2013-09-30,2013-11-07 17:23:11+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,136000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,,2013-09-30,2013-11-07 17:23:11+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,246043000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,,2013-09-30,2013-11-07 17:23:11+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,24998000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,,2013-09-30,2013-11-07 17:23:11+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,26245000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,,2013-09-30,2013-11-07 17:23:11+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,8617000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,,2013-09-30,2013-11-07 17:23:11+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,28940000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,,2013-09-30,2013-11-07 17:23:11+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,6558000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,,2013-09-30,2013-11-07 17:23:11+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,387803000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,,2013-09-30,2013-11-07 17:23:11+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,17752000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,,2013-09-30,2013-11-07 17:23:11+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,57069000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,,2013-09-30,2013-11-07 17:23:11+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,17590000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,,2013-09-30,2013-11-07 17:23:11+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,101725000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,,2013-09-30,2013-11-07 17:23:11+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,4708000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,,2013-09-30,2013-11-07 17:23:11+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,181092000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,,2013-09-30,2013-11-07 17:23:11+00:00,,totalassets,Total Assets,=,debit,usd,586647000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,,2013-09-30,2013-11-07 17:23:11+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,2153000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,,2013-09-30,2013-11-07 17:23:11+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,15907000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,,2013-09-30,2013-11-07 17:23:11+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,29920000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,,2013-09-30,2013-11-07 17:23:11+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,40278000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,,2013-09-30,2013-11-07 17:23:11+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,0.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,,2013-09-30,2013-11-07 17:23:11+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,88258000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,,2013-09-30,2013-11-07 17:23:11+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,3855000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,,2013-09-30,2013-11-07 17:23:11+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,61892000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,,2013-09-30,2013-11-07 17:23:11+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,6251000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,,2013-09-30,2013-11-07 17:23:11+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,71998000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,,2013-09-30,2013-11-07 17:23:11+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,160256000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,,2013-09-30,2013-11-07 17:23:11+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,670896000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,,2013-09-30,2013-11-07 17:23:11+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-244274000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,,2013-09-30,2013-11-07 17:23:11+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,329000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,,2013-09-30,2013-11-07 17:23:11+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,98000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,,2013-09-30,2013-11-07 17:23:11+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,427049000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,,2013-09-30,2013-11-07 17:23:11+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,426391000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,,2013-09-30,2013-11-07 17:23:11+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,426391000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2013.0,Q3,,2013-09-30,2013-11-07 17:23:11+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,586647000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,,2014-03-31,2014-05-09 16:56:49+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,44355000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,,2014-03-31,2014-05-09 16:56:49+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,259000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,,2014-03-31,2014-05-09 16:56:49+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,226065000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,,2014-03-31,2014-05-09 16:56:49+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,29265000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,,2014-03-31,2014-05-09 16:56:49+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,31154000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,,2014-03-31,2014-05-09 16:56:49+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,8101000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,,2014-03-31,2014-05-09 16:56:49+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,16493000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,,2014-03-31,2014-05-09 16:56:49+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,7727000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,,2014-03-31,2014-05-09 16:56:49+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,363419000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,,2014-03-31,2014-05-09 16:56:49+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,16440000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,,2014-03-31,2014-05-09 16:56:49+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,101732000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,,2014-03-31,2014-05-09 16:56:49+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,17959000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,,2014-03-31,2014-05-09 16:56:49+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,107985000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,,2014-03-31,2014-05-09 16:56:49+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,4352000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,,2014-03-31,2014-05-09 16:56:49+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,232028000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,,2014-03-31,2014-05-09 16:56:49+00:00,,totalassets,Total Assets,=,debit,usd,611887000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,,2014-03-31,2014-05-09 16:56:49+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1594000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,,2014-03-31,2014-05-09 16:56:49+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,21506000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,,2014-03-31,2014-05-09 16:56:49+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,31331000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,,2014-03-31,2014-05-09 16:56:49+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,40274000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,,2014-03-31,2014-05-09 16:56:49+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,0.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,,2014-03-31,2014-05-09 16:56:49+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,94705000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,,2014-03-31,2014-05-09 16:56:49+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,2455000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,,2014-03-31,2014-05-09 16:56:49+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,57363000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,,2014-03-31,2014-05-09 16:56:49+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,6844000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,,2014-03-31,2014-05-09 16:56:49+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,66662000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,,2014-03-31,2014-05-09 16:56:49+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,161367000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,,2014-03-31,2014-05-09 16:56:49+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,688146000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,,2014-03-31,2014-05-09 16:56:49+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-237379000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,,2014-03-31,2014-05-09 16:56:49+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,329000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,,2014-03-31,2014-05-09 16:56:49+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,82000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,,2014-03-31,2014-05-09 16:56:49+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,451178000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,,2014-03-31,2014-05-09 16:56:49+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,450520000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,,2014-03-31,2014-05-09 16:56:49+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,450520000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q1,,2014-03-31,2014-05-09 16:56:49+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,611887000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,,2014-06-30,2014-08-07 16:42:31+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,274599000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,,2014-06-30,2014-08-07 16:42:31+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,331254000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,,2014-06-30,2014-08-07 16:42:31+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,27027000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,,2014-06-30,2014-08-07 16:42:31+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,31401000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,,2014-06-30,2014-08-07 16:42:31+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,8272000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,,2014-06-30,2014-08-07 16:42:31+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,10452000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,,2014-06-30,2014-08-07 16:42:31+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,10124000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,,2014-06-30,2014-08-07 16:42:31+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,693129000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,,2014-06-30,2014-08-07 16:42:31+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,15823000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,,2014-06-30,2014-08-07 16:42:31+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,121855000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,,2014-06-30,2014-08-07 16:42:31+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,17281000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,,2014-06-30,2014-08-07 16:42:31+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,84885000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,,2014-06-30,2014-08-07 16:42:31+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,10344000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,,2014-06-30,2014-08-07 16:42:31+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,234365000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,,2014-06-30,2014-08-07 16:42:31+00:00,,totalassets,Total Assets,=,debit,usd,943317000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,,2014-06-30,2014-08-07 16:42:31+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1369000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,,2014-06-30,2014-08-07 16:42:31+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,20660000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,,2014-06-30,2014-08-07 16:42:31+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,34064000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,,2014-06-30,2014-08-07 16:42:31+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,38519000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,,2014-06-30,2014-08-07 16:42:31+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,0.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,,2014-06-30,2014-08-07 16:42:31+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,94612000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,,2014-06-30,2014-08-07 16:42:31+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,286341000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,,2014-06-30,2014-08-07 16:42:31+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,55099000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,,2014-06-30,2014-08-07 16:42:31+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,6886000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,,2014-06-30,2014-08-07 16:42:31+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,348326000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,,2014-06-30,2014-08-07 16:42:31+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,442938000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,,2014-06-30,2014-08-07 16:42:31+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,733306000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,,2014-06-30,2014-08-07 16:42:31+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-232694000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,,2014-06-30,2014-08-07 16:42:31+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,329000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,,2014-06-30,2014-08-07 16:42:31+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,96000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,,2014-06-30,2014-08-07 16:42:31+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,501037000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,,2014-06-30,2014-08-07 16:42:31+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,500379000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,,2014-06-30,2014-08-07 16:42:31+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,500379000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q2,,2014-06-30,2014-08-07 16:42:31+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,943317000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,,2014-09-30,2014-11-07 15:47:46+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,53341000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,,2014-09-30,2014-11-07 15:47:46+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,194000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,,2014-09-30,2014-11-07 15:47:46+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,713100000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,,2014-09-30,2014-11-07 15:47:46+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,24792000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,,2014-09-30,2014-11-07 15:47:46+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,27215000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,,2014-09-30,2014-11-07 15:47:46+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,9000000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,,2014-09-30,2014-11-07 15:47:46+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,5873000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,,2014-09-30,2014-11-07 15:47:46+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,10374000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,,2014-09-30,2014-11-07 15:47:46+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,843889000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,,2014-09-30,2014-11-07 15:47:46+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,17089000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,,2014-09-30,2014-11-07 15:47:46+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,16865000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,,2014-09-30,2014-11-07 15:47:46+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,84885000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,,2014-09-30,2014-11-07 15:47:46+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,10039000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,,2014-09-30,2014-11-07 15:47:46+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,111789000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,,2014-09-30,2014-11-07 15:47:46+00:00,,totalassets,Total Assets,=,debit,usd,972767000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,,2014-09-30,2014-11-07 15:47:46+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,2057000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,,2014-09-30,2014-11-07 15:47:46+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,20507000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,,2014-09-30,2014-11-07 15:47:46+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,39785000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,,2014-09-30,2014-11-07 15:47:46+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,38572000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,,2014-09-30,2014-11-07 15:47:46+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,0.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,,2014-09-30,2014-11-07 15:47:46+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,100921000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,,2014-09-30,2014-11-07 15:47:46+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,287998000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,,2014-09-30,2014-11-07 15:47:46+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,52835000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,,2014-09-30,2014-11-07 15:47:46+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,8100000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,,2014-09-30,2014-11-07 15:47:46+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,348933000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,,2014-09-30,2014-11-07 15:47:46+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,449854000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,,2014-09-30,2014-11-07 15:47:46+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,743817000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,,2014-09-30,2014-11-07 15:47:46+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-220741000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,,2014-09-30,2014-11-07 15:47:46+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,329000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,,2014-09-30,2014-11-07 15:47:46+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,166000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,,2014-09-30,2014-11-07 15:47:46+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,523571000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,,2014-09-30,2014-11-07 15:47:46+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,522913000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,,2014-09-30,2014-11-07 15:47:46+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,522913000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2014.0,Q3,,2014-09-30,2014-11-07 15:47:46+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,972767000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,61515000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,1243000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,238182000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,30551000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,45831000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,19050000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,20469000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,6995000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,423836000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,45919000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,182952000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,432155000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,9311000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,4809000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,629227000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,,totalassets,Total Assets,=,debit,usd,1098982000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1893000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,21886000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,60208000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,38178000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,0.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,122165000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,290665000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,48306000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,23885000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,64941000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,427797000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,549962000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,772935000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-223495000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,329000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-91000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,549678000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,549020000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,549020000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q1,,2015-03-31,2015-05-08 17:18:09+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1098982000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,76197000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,900000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,225523000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,29797000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,49202000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,18526000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,19321000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,8167000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,427633000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,44453000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,182952000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,431759000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,8944000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,4809000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,628464000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,,totalassets,Total Assets,=,debit,usd,1100550000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1729000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,16947000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,55535000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,37460000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,0.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,111671000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,292612000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,46042000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,23885000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,66056000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,428595000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,540266000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,783171000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-222498000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,329000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-60000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,560942000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,560284000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,560284000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q2,,2015-06-30,2015-08-07 16:49:47+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1100550000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,89837000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,1139000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,233593000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,31755000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,46838000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,13876000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,4967000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,7563000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,429568000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,42415000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,183636000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,431279000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,8571000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,4809000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,628295000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,,totalassets,Total Assets,=,debit,usd,1100278000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1705000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,14005000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,68472000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,9057000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,0.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,93239000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,294583000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,43777000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,24568000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,69223000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,432151000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,525390000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,793817000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-218557000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,329000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-43000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,575546000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,574888000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,574888000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2015.0,Q3,,2015-09-30,2015-11-09 16:48:16+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1100278000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,,2016-03-31,2016-05-06 17:08:50+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,431414000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,,2016-03-31,2016-05-06 17:08:50+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,190000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,,2016-03-31,2016-05-06 17:08:50+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,41623000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,,2016-03-31,2016-05-06 17:08:50+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,39667000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,,2016-03-31,2016-05-06 17:08:50+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,14312000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,,2016-03-31,2016-05-06 17:08:50+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,17075000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,,2016-03-31,2016-05-06 17:08:50+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,544281000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,,2016-03-31,2016-05-06 17:08:50+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,38027000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,,2016-03-31,2016-05-06 17:08:50+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,183636000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,,2016-03-31,2016-05-06 17:08:50+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,430491000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,,2016-03-31,2016-05-06 17:08:50+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,12273000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,,2016-03-31,2016-05-06 17:08:50+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2986000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,,2016-03-31,2016-05-06 17:08:50+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,629386000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,,2016-03-31,2016-05-06 17:08:50+00:00,,totalassets,Total Assets,=,debit,usd,1211694000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,,2016-03-31,2016-05-06 17:08:50+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1117000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,,2016-03-31,2016-05-06 17:08:50+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,21355000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,,2016-03-31,2016-05-06 17:08:50+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,73475000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,,2016-03-31,2016-05-06 17:08:50+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,9057000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,,2016-03-31,2016-05-06 17:08:50+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,0.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,,2016-03-31,2016-05-06 17:08:50+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,105004000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,,2016-03-31,2016-05-06 17:08:50+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,292624000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,,2016-03-31,2016-05-06 17:08:50+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,39249000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,,2016-03-31,2016-05-06 17:08:50+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,12146000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,,2016-03-31,2016-05-06 17:08:50+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,78659000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,,2016-03-31,2016-05-06 17:08:50+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,422678000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,,2016-03-31,2016-05-06 17:08:50+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,527682000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,,2016-03-31,2016-05-06 17:08:50+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,894213000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,,2016-03-31,2016-05-06 17:08:50+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-209872000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,,2016-03-31,2016-05-06 17:08:50+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-329000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,,2016-03-31,2016-05-06 17:08:50+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,684012000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,,2016-03-31,2016-05-06 17:08:50+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,684012000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,,2016-03-31,2016-05-06 17:08:50+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,684012000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q1,,2016-03-31,2016-05-06 17:08:50+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1211694000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,,2016-06-30,2016-08-04 17:25:32+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,137400000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,,2016-06-30,2016-08-04 17:25:32+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,45886000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,,2016-06-30,2016-08-04 17:25:32+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,55553000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,,2016-06-30,2016-08-04 17:25:32+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,18709000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,,2016-06-30,2016-08-04 17:25:32+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,5616000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,,2016-06-30,2016-08-04 17:25:32+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,263164000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,,2016-06-30,2016-08-04 17:25:32+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,36754000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,,2016-06-30,2016-08-04 17:25:32+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,284504000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,,2016-06-30,2016-08-04 17:25:32+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,751524000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,,2016-06-30,2016-08-04 17:25:32+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,2128000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,,2016-06-30,2016-08-04 17:25:32+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,8465000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,,2016-06-30,2016-08-04 17:25:32+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1046621000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,,2016-06-30,2016-08-04 17:25:32+00:00,,totalassets,Total Assets,=,debit,usd,1346539000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,,2016-06-30,2016-08-04 17:25:32+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1126000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,,2016-06-30,2016-08-04 17:25:32+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,29554000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,,2016-06-30,2016-08-04 17:25:32+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,96388000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,,2016-06-30,2016-08-04 17:25:32+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,9057000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,,2016-06-30,2016-08-04 17:25:32+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,0.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,,2016-06-30,2016-08-04 17:25:32+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,136125000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,,2016-06-30,2016-08-04 17:25:32+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,294854000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,,2016-06-30,2016-08-04 17:25:32+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,36984000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,,2016-06-30,2016-08-04 17:25:32+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,89960000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,,2016-06-30,2016-08-04 17:25:32+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,107074000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,,2016-06-30,2016-08-04 17:25:32+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,528872000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,,2016-06-30,2016-08-04 17:25:32+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,664997000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,,2016-06-30,2016-08-04 17:25:32+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,904830000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,,2016-06-30,2016-08-04 17:25:32+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-228152000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,,2016-06-30,2016-08-04 17:25:32+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-329000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,,2016-06-30,2016-08-04 17:25:32+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-4711000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,,2016-06-30,2016-08-04 17:25:32+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,671638000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,,2016-06-30,2016-08-04 17:25:32+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,671638000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,,2016-06-30,2016-08-04 17:25:32+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,9904000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,,2016-06-30,2016-08-04 17:25:32+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,681542000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q2,,2016-06-30,2016-08-04 17:25:32+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1346539000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,,2016-09-30,2016-11-07 17:24:47+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,127940000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,,2016-09-30,2016-11-07 17:24:47+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,48575000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,,2016-09-30,2016-11-07 17:24:47+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,40935000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,,2016-09-30,2016-11-07 17:24:47+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,15639000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,,2016-09-30,2016-11-07 17:24:47+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,4863000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,,2016-09-30,2016-11-07 17:24:47+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,237952000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,,2016-09-30,2016-11-07 17:24:47+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,35777000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,,2016-09-30,2016-11-07 17:24:47+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,284029000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,,2016-09-30,2016-11-07 17:24:47+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,749415000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,,2016-09-30,2016-11-07 17:24:47+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,2951000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,,2016-09-30,2016-11-07 17:24:47+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,8244000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,,2016-09-30,2016-11-07 17:24:47+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1044639000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,,2016-09-30,2016-11-07 17:24:47+00:00,,totalassets,Total Assets,=,debit,usd,1318368000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,,2016-09-30,2016-11-07 17:24:47+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1134000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,,2016-09-30,2016-11-07 17:24:47+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,18557000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,,2016-09-30,2016-11-07 17:24:47+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,89374000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,,2016-09-30,2016-11-07 17:24:47+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,9057000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,,2016-09-30,2016-11-07 17:24:47+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,0.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,,2016-09-30,2016-11-07 17:24:47+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,118122000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,,2016-09-30,2016-11-07 17:24:47+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,297111000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,,2016-09-30,2016-11-07 17:24:47+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,34720000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,,2016-09-30,2016-11-07 17:24:47+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,91429000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,,2016-09-30,2016-11-07 17:24:47+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,110220000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,,2016-09-30,2016-11-07 17:24:47+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,533480000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,,2016-09-30,2016-11-07 17:24:47+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,651602000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,,2016-09-30,2016-11-07 17:24:47+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,911586000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,,2016-09-30,2016-11-07 17:24:47+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-240876000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,,2016-09-30,2016-11-07 17:24:47+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-329000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,,2016-09-30,2016-11-07 17:24:47+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-3615000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,,2016-09-30,2016-11-07 17:24:47+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,666766000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,,2016-09-30,2016-11-07 17:24:47+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,666766000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,,2016-09-30,2016-11-07 17:24:47+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,666766000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2016.0,Q3,,2016-09-30,2016-11-07 17:24:47+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1318368000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,,2017-03-31,2017-05-09 17:15:38+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,133619000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,,2017-03-31,2017-05-09 17:15:38+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,61000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,,2017-03-31,2017-05-09 17:15:38+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,50238000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,,2017-03-31,2017-05-09 17:15:38+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,46054000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,,2017-03-31,2017-05-09 17:15:38+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,13615000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,,2017-03-31,2017-05-09 17:15:38+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,4565000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,,2017-03-31,2017-05-09 17:15:38+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,248152000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,,2017-03-31,2017-05-09 17:15:38+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,37132000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,,2017-03-31,2017-05-09 17:15:38+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,278069000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,,2017-03-31,2017-05-09 17:15:38+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,740838000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,,2017-03-31,2017-05-09 17:15:38+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,4400000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,,2017-03-31,2017-05-09 17:15:38+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,11251000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,,2017-03-31,2017-05-09 17:15:38+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1034558000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,,2017-03-31,2017-05-09 17:15:38+00:00,,totalassets,Total Assets,=,debit,usd,1319842000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,,2017-03-31,2017-05-09 17:15:38+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,754000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,,2017-03-31,2017-05-09 17:15:38+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,21378000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,,2017-03-31,2017-05-09 17:15:38+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,88146000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,,2017-03-31,2017-05-09 17:15:38+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,9057000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,,2017-03-31,2017-05-09 17:15:38+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,119335000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,,2017-03-31,2017-05-09 17:15:38+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,326366000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,,2017-03-31,2017-05-09 17:15:38+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,30191000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,,2017-03-31,2017-05-09 17:15:38+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,76130000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,,2017-03-31,2017-05-09 17:15:38+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,91693000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,,2017-03-31,2017-05-09 17:15:38+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,524380000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,,2017-03-31,2017-05-09 17:15:38+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,643715000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,,2017-03-31,2017-05-09 17:15:38+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,,2017-03-31,2017-05-09 17:15:38+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,937712000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,,2017-03-31,2017-05-09 17:15:38+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-250757000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,,2017-03-31,2017-05-09 17:15:38+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-329000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,,2017-03-31,2017-05-09 17:15:38+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-10499000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,,2017-03-31,2017-05-09 17:15:38+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,676127000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,,2017-03-31,2017-05-09 17:15:38+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,676127000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,,2017-03-31,2017-05-09 17:15:38+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,676127000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q1,,2017-03-31,2017-05-09 17:15:38+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1319842000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,,2017-06-30,2017-08-08 17:27:47+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,141135000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,,2017-06-30,2017-08-08 17:27:47+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,55626000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,,2017-06-30,2017-08-08 17:27:47+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,43914000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,,2017-06-30,2017-08-08 17:27:47+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,10190000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,,2017-06-30,2017-08-08 17:27:47+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,4744000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,,2017-06-30,2017-08-08 17:27:47+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,255609000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,,2017-06-30,2017-08-08 17:27:47+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,37368000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,,2017-06-30,2017-08-08 17:27:47+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,281896000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,,2017-06-30,2017-08-08 17:27:47+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,742704000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,,2017-06-30,2017-08-08 17:27:47+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,4400000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,,2017-06-30,2017-08-08 17:27:47+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,10465000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,,2017-06-30,2017-08-08 17:27:47+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1039465000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,,2017-06-30,2017-08-08 17:27:47+00:00,,totalassets,Total Assets,=,debit,usd,1332442000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,,2017-06-30,2017-08-08 17:27:47+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,615000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,,2017-06-30,2017-08-08 17:27:47+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,19967000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,,2017-06-30,2017-08-08 17:27:47+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,77503000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,,2017-06-30,2017-08-08 17:27:47+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,9057000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,,2017-06-30,2017-08-08 17:27:47+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,107142000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,,2017-06-30,2017-08-08 17:27:47+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,328097000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,,2017-06-30,2017-08-08 17:27:47+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,27927000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,,2017-06-30,2017-08-08 17:27:47+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,79556000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,,2017-06-30,2017-08-08 17:27:47+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,100000000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,,2017-06-30,2017-08-08 17:27:47+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,535580000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,,2017-06-30,2017-08-08 17:27:47+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,642722000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,,2017-06-30,2017-08-08 17:27:47+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,,2017-06-30,2017-08-08 17:27:47+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,949391000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,,2017-06-30,2017-08-08 17:27:47+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-258953000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,,2017-06-30,2017-08-08 17:27:47+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-389000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,,2017-06-30,2017-08-08 17:27:47+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-329000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,,2017-06-30,2017-08-08 17:27:47+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,689720000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,,2017-06-30,2017-08-08 17:27:47+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,689720000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,,2017-06-30,2017-08-08 17:27:47+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,689720000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q2,,2017-06-30,2017-08-08 17:27:47+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1332442000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,,2017-09-30,2017-11-07 17:26:25+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,192496000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,,2017-09-30,2017-11-07 17:26:25+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,68000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,,2017-09-30,2017-11-07 17:26:25+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,53825000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,,2017-09-30,2017-11-07 17:26:25+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,39870000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,,2017-09-30,2017-11-07 17:26:25+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,9757000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,,2017-09-30,2017-11-07 17:26:25+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,7399000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,,2017-09-30,2017-11-07 17:26:25+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,303415000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,,2017-09-30,2017-11-07 17:26:25+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,36484000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,,2017-09-30,2017-11-07 17:26:25+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,285317000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,,2017-09-30,2017-11-07 17:26:25+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,705141000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,,2017-09-30,2017-11-07 17:26:25+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,4400000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,,2017-09-30,2017-11-07 17:26:25+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,10301000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,,2017-09-30,2017-11-07 17:26:25+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1005159000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,,2017-09-30,2017-11-07 17:26:25+00:00,,totalassets,Total Assets,=,debit,usd,1345058000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,,2017-09-30,2017-11-07 17:26:25+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,636000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,,2017-09-30,2017-11-07 17:26:25+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,21741000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,,2017-09-30,2017-11-07 17:26:25+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,78304000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,,2017-09-30,2017-11-07 17:26:25+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,9057000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,,2017-09-30,2017-11-07 17:26:25+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,109738000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,,2017-09-30,2017-11-07 17:26:25+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,331585000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,,2017-09-30,2017-11-07 17:26:25+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,25663000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,,2017-09-30,2017-11-07 17:26:25+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,98537000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,,2017-09-30,2017-11-07 17:26:25+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,99545000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,,2017-09-30,2017-11-07 17:26:25+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,555330000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,,2017-09-30,2017-11-07 17:26:25+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,665068000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,,2017-09-30,2017-11-07 17:26:25+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,,2017-09-30,2017-11-07 17:26:25+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,,2017-09-30,2017-11-07 17:26:25+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,957590000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,,2017-09-30,2017-11-07 17:26:25+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-284148000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,,2017-09-30,2017-11-07 17:26:25+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-389000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,,2017-09-30,2017-11-07 17:26:25+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,6937000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,,2017-09-30,2017-11-07 17:26:25+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,679990000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,,2017-09-30,2017-11-07 17:26:25+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,679990000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,,2017-09-30,2017-11-07 17:26:25+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,679990000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2017.0,Q3,,2017-09-30,2017-11-07 17:26:25+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1345058000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,,2018-03-31,2018-05-09 07:22:58+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,226276000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,,2018-03-31,2018-05-09 07:22:58+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,460000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,,2018-03-31,2018-05-09 07:22:58+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,106767000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,,2018-03-31,2018-05-09 07:22:58+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,50787000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,,2018-03-31,2018-05-09 07:22:58+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,27662000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,,2018-03-31,2018-05-09 07:22:58+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,14782000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,,2018-03-31,2018-05-09 07:22:58+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,1454000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,,2018-03-31,2018-05-09 07:22:58+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,428188000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,,2018-03-31,2018-05-09 07:22:58+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,39023000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,,2018-03-31,2018-05-09 07:22:58+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,289577000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,,2018-03-31,2018-05-09 07:22:58+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,429791000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,,2018-03-31,2018-05-09 07:22:58+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,494000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,,2018-03-31,2018-05-09 07:22:58+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,719862000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,,2018-03-31,2018-05-09 07:22:58+00:00,,totalassets,Total Assets,=,debit,usd,1187073000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,,2018-03-31,2018-05-09 07:22:58+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,663000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,,2018-03-31,2018-05-09 07:22:58+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,18377000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,,2018-03-31,2018-05-09 07:22:58+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,91782000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,,2018-03-31,2018-05-09 07:22:58+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,6536000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,,2018-03-31,2018-05-09 07:22:58+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,117358000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,,2018-03-31,2018-05-09 07:22:58+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,337128000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,,2018-03-31,2018-05-09 07:22:58+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,24936000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,,2018-03-31,2018-05-09 07:22:58+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,157726000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,,2018-03-31,2018-05-09 07:22:58+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,519790000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,,2018-03-31,2018-05-09 07:22:58+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,637148000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,,2018-03-31,2018-05-09 07:22:58+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,,2018-03-31,2018-05-09 07:22:58+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,,2018-03-31,2018-05-09 07:22:58+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,977928000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,,2018-03-31,2018-05-09 07:22:58+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-435725000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,,2018-03-31,2018-05-09 07:22:58+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-1591000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,,2018-03-31,2018-05-09 07:22:58+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,9313000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,,2018-03-31,2018-05-09 07:22:58+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,549925000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,,2018-03-31,2018-05-09 07:22:58+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,549925000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,,2018-03-31,2018-05-09 07:22:58+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,549925000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q1,,2018-03-31,2018-05-09 07:22:58+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1187073000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q2,,2018-06-30,2018-08-08 06:52:22+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,243345000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q2,,2018-06-30,2018-08-08 06:52:22+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,221000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q2,,2018-06-30,2018-08-08 06:52:22+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,148371000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q2,,2018-06-30,2018-08-08 06:52:22+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,64360000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q2,,2018-06-30,2018-08-08 06:52:22+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,21147000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q2,,2018-06-30,2018-08-08 06:52:22+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,15101000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q2,,2018-06-30,2018-08-08 06:52:22+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,2007000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q2,,2018-06-30,2018-08-08 06:52:22+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,494552000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q2,,2018-06-30,2018-08-08 06:52:22+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,42524000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q2,,2018-06-30,2018-08-08 06:52:22+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,284100000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q2,,2018-06-30,2018-08-08 06:52:22+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,428762000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q2,,2018-06-30,2018-08-08 06:52:22+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,678000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q2,,2018-06-30,2018-08-08 06:52:22+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,713540000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q2,,2018-06-30,2018-08-08 06:52:22+00:00,,totalassets,Total Assets,=,debit,usd,1250616000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q2,,2018-06-30,2018-08-08 06:52:22+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,629000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q2,,2018-06-30,2018-08-08 06:52:22+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,15400000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q2,,2018-06-30,2018-08-08 06:52:22+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,97761000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q2,,2018-06-30,2018-08-08 06:52:22+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,7081000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q2,,2018-06-30,2018-08-08 06:52:22+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,120871000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q2,,2018-06-30,2018-08-08 06:52:22+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,338377000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q2,,2018-06-30,2018-08-08 06:52:22+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,37586000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q2,,2018-06-30,2018-08-08 06:52:22+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,147147000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q2,,2018-06-30,2018-08-08 06:52:22+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,523110000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q2,,2018-06-30,2018-08-08 06:52:22+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,643981000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q2,,2018-06-30,2018-08-08 06:52:22+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q2,,2018-06-30,2018-08-08 06:52:22+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q2,,2018-06-30,2018-08-08 06:52:22+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,993339000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q2,,2018-06-30,2018-08-08 06:52:22+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-389527000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q2,,2018-06-30,2018-08-08 06:52:22+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-1976000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q2,,2018-06-30,2018-08-08 06:52:22+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,4799000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q2,,2018-06-30,2018-08-08 06:52:22+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,606635000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q2,,2018-06-30,2018-08-08 06:52:22+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,606635000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q2,,2018-06-30,2018-08-08 06:52:22+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,606635000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q2,,2018-06-30,2018-08-08 06:52:22+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1250616000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,,2018-09-30,2018-11-06 17:16:24+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,321011000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,,2018-09-30,2018-11-06 17:16:24+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,365000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,,2018-09-30,2018-11-06 17:16:24+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,139935000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,,2018-09-30,2018-11-06 17:16:24+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,51461000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,,2018-09-30,2018-11-06 17:16:24+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,10800000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,,2018-09-30,2018-11-06 17:16:24+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,16221000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,,2018-09-30,2018-11-06 17:16:24+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,6802000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,,2018-09-30,2018-11-06 17:16:24+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,546595000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,,2018-09-30,2018-11-06 17:16:24+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,52061000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,,2018-09-30,2018-11-06 17:16:24+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,283435000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,,2018-09-30,2018-11-06 17:16:24+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,428575000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,,2018-09-30,2018-11-06 17:16:24+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,419000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,,2018-09-30,2018-11-06 17:16:24+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,712429000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,,2018-09-30,2018-11-06 17:16:24+00:00,,totalassets,Total Assets,=,debit,usd,1311085000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,,2018-09-30,2018-11-06 17:16:24+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,624000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,,2018-09-30,2018-11-06 17:16:24+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,29554000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,,2018-09-30,2018-11-06 17:16:24+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,97816000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,,2018-09-30,2018-11-06 17:16:24+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,7714000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,,2018-09-30,2018-11-06 17:16:24+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,135708000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,,2018-09-30,2018-11-06 17:16:24+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,340833000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,,2018-09-30,2018-11-06 17:16:24+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,70656000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,,2018-09-30,2018-11-06 17:16:24+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,165263000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,,2018-09-30,2018-11-06 17:16:24+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,576752000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,,2018-09-30,2018-11-06 17:16:24+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,712460000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,,2018-09-30,2018-11-06 17:16:24+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,,2018-09-30,2018-11-06 17:16:24+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,,2018-09-30,2018-11-06 17:16:24+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,999927000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,,2018-09-30,2018-11-06 17:16:24+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-403439000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,,2018-09-30,2018-11-06 17:16:24+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-1976000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,,2018-09-30,2018-11-06 17:16:24+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,4113000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,,2018-09-30,2018-11-06 17:16:24+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,598625000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,,2018-09-30,2018-11-06 17:16:24+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,598625000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,,2018-09-30,2018-11-06 17:16:24+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,598625000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2018.0,Q3,,2018-09-30,2018-11-06 17:16:24+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1311085000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,,2019-03-31,2019-05-07 17:09:28+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,197093000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,,2019-03-31,2019-05-07 17:09:28+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,567000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,,2019-03-31,2019-05-07 17:09:28+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,146157000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,,2019-03-31,2019-05-07 17:09:28+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,20652000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,,2019-03-31,2019-05-07 17:09:28+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,31465000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,,2019-03-31,2019-05-07 17:09:28+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,14223000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,,2019-03-31,2019-05-07 17:09:28+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,7747000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,,2019-03-31,2019-05-07 17:09:28+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,417904000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,,2019-03-31,2019-05-07 17:09:28+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,83032000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,,2019-03-31,2019-05-07 17:09:28+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,280128000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,,2019-03-31,2019-05-07 17:09:28+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,425777000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,,2019-03-31,2019-05-07 17:09:28+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,27097000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,,2019-03-31,2019-05-07 17:09:28+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,733002000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,,2019-03-31,2019-05-07 17:09:28+00:00,,totalassets,Total Assets,=,debit,usd,1233938000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,,2019-03-31,2019-05-07 17:09:28+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,8783000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,,2019-03-31,2019-05-07 17:09:28+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,25955000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,,2019-03-31,2019-05-07 17:09:28+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,45918000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,,2019-03-31,2019-05-07 17:09:28+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,16631000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,,2019-03-31,2019-05-07 17:09:28+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,97287000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,,2019-03-31,2019-05-07 17:09:28+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,345853000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,,2019-03-31,2019-05-07 17:09:28+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,5401000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,,2019-03-31,2019-05-07 17:09:28+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,218811000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,,2019-03-31,2019-05-07 17:09:28+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,570065000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,,2019-03-31,2019-05-07 17:09:28+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,667352000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,,2019-03-31,2019-05-07 17:09:28+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,,2019-03-31,2019-05-07 17:09:28+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,,2019-03-31,2019-05-07 17:09:28+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1008844000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,,2019-03-31,2019-05-07 17:09:28+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-441448000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,,2019-03-31,2019-05-07 17:09:28+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-2185000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,,2019-03-31,2019-05-07 17:09:28+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,1375000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,,2019-03-31,2019-05-07 17:09:28+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,566586000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,,2019-03-31,2019-05-07 17:09:28+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,566586000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,,2019-03-31,2019-05-07 17:09:28+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,566586000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q1,,2019-03-31,2019-05-07 17:09:28+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1233938000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,,2019-06-30,2019-08-07 07:27:06+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,147648000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,,2019-06-30,2019-08-07 07:27:06+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,192000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,,2019-06-30,2019-08-07 07:27:06+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,149200000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,,2019-06-30,2019-08-07 07:27:06+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,21010000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,,2019-06-30,2019-08-07 07:27:06+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,28086000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,,2019-06-30,2019-08-07 07:27:06+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,9850000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,,2019-06-30,2019-08-07 07:27:06+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,2342000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,,2019-06-30,2019-08-07 07:27:06+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,358370000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,,2019-06-30,2019-08-07 07:27:06+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,113455000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,,2019-06-30,2019-08-07 07:27:06+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,281467000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,,2019-06-30,2019-08-07 07:27:06+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,418000000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,,2019-06-30,2019-08-07 07:27:06+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,26170000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,,2019-06-30,2019-08-07 07:27:06+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,725637000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,,2019-06-30,2019-08-07 07:27:06+00:00,,totalassets,Total Assets,=,debit,usd,1197462000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,,2019-06-30,2019-08-07 07:27:06+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,5605000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,,2019-06-30,2019-08-07 07:27:06+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,26724000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,,2019-06-30,2019-08-07 07:27:06+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,44594000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,,2019-06-30,2019-08-07 07:27:06+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,17028000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,,2019-06-30,2019-08-07 07:27:06+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,93951000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,,2019-06-30,2019-08-07 07:27:06+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,349017000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,,2019-06-30,2019-08-07 07:27:06+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,3069000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,,2019-06-30,2019-08-07 07:27:06+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,206588000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,,2019-06-30,2019-08-07 07:27:06+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,558674000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,,2019-06-30,2019-08-07 07:27:06+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,652625000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,,2019-06-30,2019-08-07 07:27:06+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,,2019-06-30,2019-08-07 07:27:06+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,,2019-06-30,2019-08-07 07:27:06+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1011792000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,,2019-06-30,2019-08-07 07:27:06+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-468934000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,,2019-06-30,2019-08-07 07:27:06+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-638000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,,2019-06-30,2019-08-07 07:27:06+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,2617000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,,2019-06-30,2019-08-07 07:27:06+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,544837000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,,2019-06-30,2019-08-07 07:27:06+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,544837000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,,2019-06-30,2019-08-07 07:27:06+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,544837000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q2,,2019-06-30,2019-08-07 07:27:06+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1197462000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q3,,2019-09-30,2019-11-07 17:11:56+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,119521000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q3,,2019-09-30,2019-11-07 17:11:56+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,387000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q3,,2019-09-30,2019-11-07 17:11:56+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,133636000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q3,,2019-09-30,2019-11-07 17:11:56+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,17553000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q3,,2019-09-30,2019-11-07 17:11:56+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,27396000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q3,,2019-09-30,2019-11-07 17:11:56+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,11839000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q3,,2019-09-30,2019-11-07 17:11:56+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,4005000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q3,,2019-09-30,2019-11-07 17:11:56+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,314337000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q3,,2019-09-30,2019-11-07 17:11:56+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,130585000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q3,,2019-09-30,2019-11-07 17:11:56+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,0.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q3,,2019-09-30,2019-11-07 17:11:56+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,410023000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q3,,2019-09-30,2019-11-07 17:11:56+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,24968000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q3,,2019-09-30,2019-11-07 17:11:56+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,434991000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q3,,2019-09-30,2019-11-07 17:11:56+00:00,,totalassets,Total Assets,=,debit,usd,879913000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q3,,2019-09-30,2019-11-07 17:11:56+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,4474000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q3,,2019-09-30,2019-11-07 17:11:56+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,26777000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q3,,2019-09-30,2019-11-07 17:11:56+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,43235000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q3,,2019-09-30,2019-11-07 17:11:56+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,17507000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q3,,2019-09-30,2019-11-07 17:11:56+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,91993000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q3,,2019-09-30,2019-11-07 17:11:56+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,350899000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q3,,2019-09-30,2019-11-07 17:11:56+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,2804000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q3,,2019-09-30,2019-11-07 17:11:56+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,152875000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q3,,2019-09-30,2019-11-07 17:11:56+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,506578000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q3,,2019-09-30,2019-11-07 17:11:56+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,598571000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q3,,2019-09-30,2019-11-07 17:11:56+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q3,,2019-09-30,2019-11-07 17:11:56+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q3,,2019-09-30,2019-11-07 17:11:56+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1015085000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q3,,2019-09-30,2019-11-07 17:11:56+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-732469000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q3,,2019-09-30,2019-11-07 17:11:56+00:00,totalcommonequity,treasurystock,Treasury Stock,+,credit,usd,-638000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q3,,2019-09-30,2019-11-07 17:11:56+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-636000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q3,,2019-09-30,2019-11-07 17:11:56+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,281342000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q3,,2019-09-30,2019-11-07 17:11:56+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,281342000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q3,,2019-09-30,2019-11-07 17:11:56+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,281342000.0
Acorda Therapeutics Inc,ACOR,5493007NPB5YRM8QGL53,0001008848,2019.0,Q3,,2019-09-30,2019-11-07 17:11:56+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,879913000.0
